Nicholas Investment Partners’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.45M | Sell |
255,107
-356,630
| -58% | -$6.22M | 0.4% | 101 |
|
|
2025
Q1 | $7.7M | Buy |
611,737
+439,719
| +256% | +$5.53M | 0.79% | 37 |
|
|
2024
Q4 | $1.81M | Sell |
172,018
-29,753
| -15% | -$314K | 0.16% | 163 |
|
|
2024
Q3 | $2.93M | Buy |
+201,771
| New | +$2.93M | 0.27% | 137 |
|
|
2023
Q3 | – | Sell |
-275,000
| Closed | -$1.84M | – | 201 |
|
|
2023
Q2 | $1.84M | Sell |
275,000
-480,622
| -64% | -$3.22M | 0.13% | 143 |
|
|
2023
Q1 | $4.92M | Buy |
+755,622
| New | +$4.92M | 0.37% | 66 |
|